No coercive steps against drug firms for FDCs in market: Delhi HC

Around five pharma firms had filed writ petitions in the Delhi High Court challenging the September 7 notification by the Ministry of Health and Family Welfare

The Delhi High Court on Tuesday issued a notice on the writ petitions filed by pharma majors such as Glenmark, Lupin, and Mankind, among others challenging the ban on close to 40 products out of the 328 fixed dose combinations (FDCs), directing that no coercive steps be taken against petitioners and their stockists or dealers for the existing stock already in circulation. 

The matter came up before the single judge bench of the Delhi High Court of Justice Vibhu Bakhru. The court said no coercive steps be taken by government agencies as overnight recall of drugs from across the country is